Mechanisms of the age-associated deterioration in glucose tolerance: Contribution of alterations in insulin secretion, action, and clearance

Diabetes

Volumn 52, Issue 7, 2003, Pages 1738-1748

  Basu, Rita ^a   Breda, Elena ^b   Oberg, Ann L ^a   Powell, Claudia C ^a   Man, Chiara Dalla ^b   Basu, Ananda ^a   Vittone, Janet L ^a   Klee, George G ^a   Arora, Puneet ^a   Jensen, Michael D ^a   Toffolo, Gianna ^b   Cobelli, Claudio ^b   Rizza, Robert A ^a,c  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGE; AGED; ARTICLE; B LYMPHOCYTE; BODY FAT; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN CLEARANCE; INSULIN RELEASE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

EID: 0038353641     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.7.1738     Document Type: Article

References (54)

1. Chen M, Bergman RN, Pacini G, Porte D Jr: Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased β-cell function. J Clin Endocrinol Metab 60:13-20, 1985
2. Coon PJ, Rogus EM, Drinkwater D, Muller DC, Goldberg AP: Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age. J Clin Endocrinol Metab 75:1125-1132, 1992
3. DeFronzo RA: Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes 28:1095-1101, 1979
4. O'Shaughnessy IM, Kasdorf GM, Hoffmann RG, Kalkhoff RK: Does aging intensify the insulin resistance of human obesity? J Clin Endocrinol Metab 74:1075-1081, 1992
5. Rowe JW, Minaker KL, Pallotta JA, Flier JS: Characterization of the insulin resistance of aging. J Clin Invest 71:1581-1587, 1983
6. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U: European Group for the Study of Insulin Resistance (EGIR): insulin action and age. Diabetes 45:947-953, 1996
7. Ahren B, Pacini G: Age-related reduction in glucose elimination is accompanied by reduced glucose effectiveness and increased hepatic insulin extraction in man. J Clin Endocrinol Metab 83:3350-3356, 1998
8. Pacini G, Valerio A, Beccaro F, Nosadini R, Cobelli C, Crepaldi G: Insulin sensitivity and beta-cell responsivity are not decreased in elderly subjects with normal OGTT. J Am Geriatr Soc 36:317-323, 1988
9. Boden G, Chen X, DeSantis RA, Kendrick Z: Effects of age and body fat on insulin resistance in healthy men. Diabetes Care 16:728-733, 1993
10. Broughton DL, James OWF, Alberti KGMM, Taylor R: Peripheral and hepatic insulin sensitivity in healthy elderly human subjects. Eur J Clin Invest 21:13-21, 1991
11. Dechenes CJ, Verchere CB, Andrikopoulos S, Kahn SE: Human aging is associated with parallel reductions in insulin and amylin release. Am J Physiol Endocrinol Metab 275:E785-E791, 1998
12. Bourey RE, Kohrt WM, Kirwan JP, Staten MA, King DS, Holloszy JO: Relationship between glucose tolerance and glucose-stimulated insulin response in 65-year-olds. J Gerontol 48:M122-M127, 1993
13. Elahi D, Muller DC, McAloon-Dyke M, Tobin D, Andres R: The effect of age on insulin response and glucose utilization during four hyperglycemic plateaus. Exp Gerontol 28:393-409, 1993
14. Pacini G, Beccaro F, Valerio A, Nosadini R, Crepaldi G: Reduced beta-cell secretion and insulin hepatic extraction in healthy elderly subjects. J Am Geriatr Soc 38:1283-1289, 1990
15. Gumbiner B, Polonsky KS, Beltz WF, Wallace P, Brechtel G, Fink RI: Effects of aging on insulin secretion. Diabetes 38:1549-1556, 1989
16. Jackson RA, Hawa MI, Roshania RD, Sim BM, DiSilvio L, Jaspan JB: Influence of aging on hepatic and peripheral glucose metabolism in humans. Diabetes 36:119-129, 1988
17. Dowse GK, Zimmet PZ, Alberti KGMM, Brigham L, Carlin JB, Tuomilehto J, Knight LT, Gareeboo H: Serum insulin distributions and reproducibility of the relationship between 2-hour insulin and plasma glucose levels in Asian Indian, Creole, and Chinese Mauritians. Metabolism 42:1232-1241, 1993
18. Shapiro ET, Tillil H, Miller MA, Frank BH, Galloway JA, Rubenstein AH, Polonsky KS: Insulin secretion and clearance: comparison after oral and intravenous glucose. Diabetes 36:1365-1371, 1987
19. Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W: Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. J Clin Endocrinol Metab 76:912-917, 1993
20. Zander M, Madsbad S, Madsen JL, Holst JJ: Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study. Lancet 359:824-830, 2002
21. Peiris AN, Mueller RA, Smith GA, Struve MF, Kissebah AH: Splanchnic insulin metabolism in obesity: influence of body fat distribution. J Clin Invest 78:1648-1657, 1986
22. Miller JP, Pratley RE, Goldberg AP, Gordon P, Rubin M, Treuth MS, Ryan AS, Hurley BF: Strength training increases insulin action in healthy 50- to 65-yr-old men. J Appl Physiol 77:1122-1127, 1994
23. Kirwan JP, Kohrt WM, Wojta DM, Bourey RE, Holloszy JO: Endurance exercise training reduces glucose-stimulated insulin levels in 60- to 70-year-old men and women. J Gerontol Med Sci 48:M84-M90, 1993
24. Rizza R, Mandarino L, Gerich J: Cortisol induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a post-receptor defect of insulin action. J Clin Endocrinol Metab 54:131-138, 1982
25. Rizza RA, Mandarino LJ, Gerich JE: Effect of growth hormone on insulin action in man: mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31:663-669, 1982
26. Nielsen MF, Wise S, Dinneen SF, Schwenk WF, Basu A, Rizza RA: Assessment of hepatic sensitivity to glucagon in NIDDM. Diabetes 46:2007-2016, 1997
27. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JP, Palmer JP, Port DJ: Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes 42:1663-1672, 1993
28. Bergman RN: Toward physiological understanding of glucose tolerance: the minimal model approach. Lilly Award Lecture. Diabetes 38:1512-1527, 1989
29. Bergman RN, Ader M, Huecking K, Van Citters G: Accurate assessment of B-cell function: the hyperbolic correction. Diabetes 51 (Suppl. 1):S212-S220, 2002
30. Vermeulen A, Kaufman JM, Giagulli VA: Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 81:1821-1826, 1996
31. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR: Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86:724-731, 2001
32. Miles JM, Ellman MG, McClean KL, Jensen MD: Validation of a new method for the determination of free fatty acid turnover. Am J Physiol 252:E431-E438, 1987
33. Jensen MD, Kanaley JA, Reed JE, Sheedy PF: Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry. Am J Clin Nutr 61:274-278, 1995
34. Proctor DN, Sinning WE, Walro JM, Sieck GC, Lemon PW: Oxidative capacity of human muscle fiber types: effects of age and training status. J Appl Physiol 78:2033-2038, 1995
35. Taafe DR, Marcus R: Dynamic muscle strength alterations to detraining and retraining in elderly men. Clin Physiol 17:311-324, 1997
36. Dalla Man C, Caumo A, Cobelli C: The oral glucose minimal model: estimation of insulin sensitivity from a meal test. IEEE Trans Biomed Eng 49:419-429, 2002
37. Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C: Oral glucose tolerance test minimal model indexes of β-cell function and insulin sensitivity. Diabetes 50:150-158, 2001
38. Basu R, Di Camillo B, Toffolo G, Basu A, Shah P, Vella A, Rizza R, Cobelli C: Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol Endocrinol Metab 284:E55-E69, 2003
39. Bergman RN, Ider YZ, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667-E677, 1979
40. Toffolo G, De Grandi F, Cobelli C: Estimation of β-cell sensitivity from intravenous glucose tolerance tests C-peptide data. Diabetes 44:845-854, 1995
41. Toffolo G, Cefalu WT, Cobelli C: β-cell function during insulin-modified intravenous glucose tolerance test successfully assessed by the C-peptide minimal model. Metabolism 48:1162-1166, 1999
42. Van Cauter E, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377, 1992
43. Bergman RN, Phillips SP, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man. J Clin Invest 68:1456-1467, 1981
44. Toffolo G, Arduini A, De Zanche N, Avogaro A, Cobelli C: A minimal model of insulin during insulin modified IVGTT: assessment of hepatic insulin extraction. In Proceedings of the 3rd IFAC Symposium on Modeling and Control in Biomedical Systems. Linkens DA, Carson E, Eds. Elsevier, Amsterdam, 1997, p. 91-95
45. Toffolo G, Cobelli C: Insulin modelling. In Modelling Methodology for Physiology and Medicine. Carson E, Cobelli C, Eds. London, UK, Academic Press, 2001, p. 305-333
46. Barret PHR, Bell BM, Cobelli C, Golde H, Schumitzky A, Vicini P, Foster D: SAAM II: simulation, analysis and modeling software for tracer and pharmacokinetic studies. Metabolism 47:484-492, 1998
47. Seals DR, Hagberg JM, Allen WK, Hurley BF, Dalsky GP, Ehsani AA, Holloszy JO: Glucose tolerance in young and older athletes and sedentary men. Am J Physiol 56:1521-1525, 1984
48. Fink RI, Revers RR, Kolterman OG, Olefsky JM: The metabolic clearance of insulin and the feedback inhibition of insulin secretion are altered with aging. Diabetes 34:275-280, 1985
49. Minaker KL, Rowe JM, Tonino R, Pallotta JA: Influence of age on clearance of insulin in man. Diabetes 31:851-855, 1982
50. Meneilly GS, Ryan AS, Veldhuis JD, Elahi D: Increased disorderliness of basal insulin release, attenuated insulin secretory burst mass, and reduced ultradian rhythmicity of insulin secretion in older individuals. J Clin Endocrinol Metab 82:4088-4093, 1997
51. Meneilly GS, Veldhuis JD, Elahi D: Disruption of the pulsatile and entropic modes of insulin release during an unvarying glucose stimulus in elderly individuals. J Clin Endocrinol Metab 84:1938-1943, 1999
52. Halban PE: Differential rates of release of newly synthesized and of stored insulin from pancreatic islets. Endocrinology 110:1183-1188, 1982
53. Draznin B, Steinberg JP, Goodman M, Leitner JW, Sussman KE: Control of secretion vesicle margination and lysis by glucose, IBMX, and glyburide. Am J Physiol E375-E380, 1985
54. Kjems LL, Kirby BM, Welsh EM, Veldhuis JD, Straume M, McIntyre SS, Yang D, Lefebvre P, Butler PC: Decrease in β-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. Diabetes 50:2001-2012, 2001